The Predictive Role of Proteomics in Blood Pressure Response of Hypertensive Patients Undergoing Renal Denervation.

Renal Denervation (RDN) is a treatment for high blood pressure (hypertension), using a special tube called a catheter to send energy to kidney nerves. This study looks at how proteins in urine might help predict who will benefit from RDN. Proteomics is the study of proteins, which are important molecules in our body. By studying urine proteins, researchers hope to identify which patients will see the best blood pressure improvements after RDN.

Participants should be adults aged 18-80 with high blood pressure, confirmed through tests. They will provide urine samples before the RDN procedure, and have their blood pressure checked three months later. Researchers will compare protein differences in those whose blood pressure improves and those who don't respond as well.

• Study involves one RDN procedure and follow-up visit three months later.
• Participants must not have severe kidney disease or type I diabetes.
• Compensation for study participation is not mentioned.

This research could help doctors choose the best patients for RDN, making treatment more effective. 🩺💉